COVID-19 pandemic

Dr Rama Akondy, Associate Professor of Biology, Ashoka University highlights that by fostering clinical and research partnerships,…

UX053 was one of five non-vaccine mRNA therapeutics in clinical trial development. The other four are all currently in Phase I/II…

mRNA-3927 targets a rare genetic disorder, propionic acidemia, in which patients are unable to process certain parts of proteins…

Ankur Gupta, Director, Sales Strategy, Moglix outlines measures to bolster pharma operations and tackle challenges faced by pharma…

While trade agreements with Australia, the UK, Canada and Bangladesh are nearing completion, and discussions with the EU and…

The report highlights the trends in pharma crime and incidents of sub-standard and falsified (SF) medical products during COVID-19…

Sudesh Verma, Member, National Media Relations Department, BJP, explains the need to showcase grit and determination to take…

As 2021 is about to end, a few stakeholders from the pharma industry share some key lessons learnt in the past year

Shalini Kamath, Independent Director on the Boards of Abbott, talks to Ashwini Prakash, Managing Partner India, Asia Pacific Lead…

Anisha Motwani, Independent Brand, Digital and Innovation Consultant, Board Director, talks about the board room idea, culture and…